New scan could help doctors choose best treatment for kidney tumors

NCT ID NCT03996850

Ongoing Diagnosis Sponsor: Jonsson Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a special type of scan called SPECT/CT can help doctors make better decisions about treating kidney tumors. The scan uses a radioactive tracer to see how tumors behave. Researchers will check if the scan changes what doctors recommend for 102 patients with new kidney tumors. The goal is to see if this less invasive method can guide treatment choices.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Technetium Tc-99m sestamibi (a radioactive tracer used in imaging)
What this could lead to: If successful, this imaging method could help doctors decide on the best treatment for kidney tumors without needing invasive biopsies.
What could go wrong: This is an early-stage study focused on decision-making, not treatment outcomes. The imaging may not change decisions as expected, and results may not apply to all kidney tumor types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

kidney cancer kidney neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KIDNEY NEOPLASM RENAL MASS

Contacts and locations

Locations

UCLA / Jonsson Comprehensive Cancer Center

Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.